Suppr超能文献

体外胆汁引流期间胆汁替代的价值:肠道通透性、完整性及微生物群分析

The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora.

作者信息

Kamiya Satoshi, Nagino Masato, Kanazawa Hidetoshi, Komatsu Shunichiro, Mayumi Toshihiko, Takagi Kenji, Asahara Takashi, Nomoto Koji, Tanaka Ryuichiro, Nimura Yuji

机构信息

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Ann Surg. 2004 Apr;239(4):510-7. doi: 10.1097/01.sla.0000118594.23874.89.

Abstract

OBJECTIVE

To investigate the effect of bile replacement following percutaneous transhepatic biliary drainage, ie, external drainage, on intestinal permeability, integrity, and microflora in a clinical setting.

SUMMARY BACKGROUND DATA

Several authors have reported that internal biliary drainage is superior to external drainage. However, it is unclear whether bile replacement following external drainage is beneficial.

METHODS

Twenty-five patients with biliary cancer underwent percutaneous transhepatic biliary drainage (PTBD) as a part of presurgical management. All externally drained bile was replaced either per os or by administration through a nasoduodenal tube. The interval between PTBD and the beginning of bile replacement was 21.3 +/- 19.7 days, and the length of bile replacement was 20.7 +/- 9.6 days. The lactulose-mannitol test, measurement of serum diamine oxidase (DAO) activity, and analyses of fecal microflora and organic acids were performed before and after bile replacement.

RESULTS

The volume of externally drained bile varied widely from patient to patient, ranging from 220 +/- 106 mL/d to 1616 +/- 394 mL/d (mean, 714 +/- 346 mL/d). Biliary concentrations of bile acids, cholesterol, and phospholipids increased significantly after bile replacement. The lactulose-mannitol (L/M) ratio decreased from 0.063 +/- 0.060 before bile replacement to 0.038 +/- 0.032 after bile replacement (P < 0.05). Serum DAO activity increased from 3.9 +/- 1.4 U/L before bile replacement to 5.1 +/- 1.6 U/L after bile replacement (P < 0.005), and the magnitude of change in serum DAO activity correlated with the length of bile replacement (r = 0.483, P < 0.05). Neither the L/M ratios nor serum DAO activities before bile replacement correlated with the interval between PTBD and the beginning of bile replacement. Fecal microflora and organic acids were unchanged.

CONCLUSION

Impaired intestinal barrier function does not recover by PTBD without bile replacement. Bile replacement during external biliary drainage can restore the intestinal barrier function in patients with biliary obstruction, primarily due to repair of physical damage to the intestinal mucosa. Our results support the hypothesis that bile replacement during external drainage is beneficial.

摘要

目的

在临床环境中研究经皮经肝胆道引流(即外引流)后胆汁替代对肠道通透性、完整性和微生物群的影响。

总结背景数据

几位作者报告称,内引流优于外引流。然而,外引流后胆汁替代是否有益尚不清楚。

方法

25例胆管癌患者在术前管理中接受了经皮经肝胆道引流(PTBD)。所有外引流胆汁均经口服或通过鼻十二指肠管给药进行替代。PTBD与开始胆汁替代之间的间隔为21.3±19.7天,胆汁替代的时长为20.7±9.6天。在胆汁替代前后进行乳果糖-甘露醇试验、血清二胺氧化酶(DAO)活性测定以及粪便微生物群和有机酸分析。

结果

外引流胆汁量在患者之间差异很大,范围为220±106 mL/天至1616±394 mL/天(平均714±346 mL/天)。胆汁替代后胆汁酸、胆固醇和磷脂的胆汁浓度显著增加。乳果糖-甘露醇(L/M)比值从胆汁替代前的0.063±0.060降至胆汁替代后的0.038±0.032(P<0.05)。血清DAO活性从胆汁替代前的3.9±1.4 U/L增加至胆汁替代后的5.1±1.6 U/L(P<0.005),血清DAO活性的变化幅度与胆汁替代时长相关(r=0.483,P<0.05)。胆汁替代前的L/M比值和血清DAO活性均与PTBD至开始胆汁替代之间的间隔无关。粪便微生物群和有机酸未发生变化。

结论

不进行胆汁替代的PTBD不能恢复受损的肠道屏障功能。外引流期间的胆汁替代可恢复胆管梗阻患者的肠道屏障功能,主要是由于肠道黏膜物理损伤的修复。我们的结果支持外引流期间胆汁替代有益的假设。

相似文献

引用本文的文献

2
Changes over time in treatment for obstructive jaundice.阻塞性黄疸治疗方法随时间的变化。
World J Gastrointest Surg. 2024 Oct 27;16(10):3074-3077. doi: 10.4240/wjgs.v16.i10.3074.
3
Cholangiocarcinoma.胆管癌。
Cancer Treat Res. 2024;192:165-184. doi: 10.1007/978-3-031-61238-1_9.

本文引用的文献

3
Complications of hepatectomy for hilar cholangiocarcinoma.肝门部胆管癌肝切除术的并发症
World J Surg. 2001 Oct;25(10):1277-83. doi: 10.1007/s00268-001-0110-8.
5
Intestinal permeability is increased in patients with intermittent claudication.
J Vasc Surg. 2000 May;31(5):1003-7. doi: 10.1067/mva.2000.105004.
6
Extended resections for hilar cholangiocarcinoma.肝门部胆管癌的扩大切除术
Ann Surg. 1999 Dec;230(6):808-18; discussion 819. doi: 10.1097/00000658-199912000-00010.
9
Aggressive surgical treatment of hilar cholangiocarcinoma.肝门部胆管癌的积极手术治疗
J Hepatobiliary Pancreat Surg. 1998;5(1):52-61. doi: 10.1007/pl00009951.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验